Oxford Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-42,161
| Closed | -$93.6K | – | 346 |
|
|
2024
Q2 | $93.6K | Buy |
+42,161
| New | +$93.6K | 0.09% | 238 |
|
|
2020
Q1 | – | Sell |
-17,182
| Closed | -$1.03M | – | 567 |
|
|
2019
Q4 | $1.03M | Sell |
17,182
-31,170
| -64% | -$1.86M | 0.03% | 849 |
|
|
2019
Q3 | $1.77M | Buy |
48,352
+737
| +2% | +$27K | 0.04% | 617 |
|
|
2019
Q2 | $2.22M | Buy |
+47,615
| New | +$2.22M | 0.05% | 597 |
|
|
2019
Q1 | – | Sell |
-23,472
| Closed | -$1.08M | – | 1738 |
|
|
2018
Q4 | $1.08M | Buy |
23,472
+12,676
| +117% | +$583K | 0.03% | 830 |
|
|
2018
Q3 | $485K | Buy |
+10,796
| New | +$485K | 0.01% | 1320 |
|
|
2018
Q2 | – | Sell |
-11,046
| Closed | -$799K | – | 1760 |
|
|
2018
Q1 | $799K | Buy |
+11,046
| New | +$799K | 0.02% | 1042 |
|
|
2017
Q4 | – | Sell |
-14,309
| Closed | -$715K | – | 1673 |
|
|
2017
Q3 | $715K | Buy |
+14,309
| New | +$715K | 0.01% | 1083 |
|
|
2017
Q2 | – | Sell |
-25,211
| Closed | -$890K | – | 1528 |
|
|
2017
Q1 | $890K | Sell |
25,211
-4,440
| -15% | -$157K | 0.02% | 852 |
|
|
2016
Q4 | $371K | Sell |
29,651
-36,290
| -55% | -$454K | 0.01% | 631 |
|
|
2016
Q3 | $913K | Sell |
65,941
-171,002
| -72% | -$2.37M | 0.03% | 532 |
|
|
2016
Q2 | $2.34M | Sell |
236,943
-43,399
| -15% | -$429K | 0.08% | 338 |
|
|
2016
Q1 | $4.74M | Buy |
280,342
+125,265
| +81% | +$2.12M | 0.14% | 172 |
|
|
2015
Q4 | $3.53M | Buy |
+155,077
| New | +$3.53M | 0.08% | 269 |
|